메뉴 건너뛰기




Volumn 54, Issue 5, 2012, Pages 515-518

Hypohidrosis and hyperthermia during topiramate treatment in children

Author keywords

Children; Hyperthermia; Hypohidrosis; Topiramate

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

EID: 84873140457     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (11)
  • 1
    • 31144438237 scopus 로고    scopus 로고
    • Efficacy and safety of topiramate in refractory epilepsy of childhood: Long-term followup study
    • Grosso S, Franzoni E, Iannetti P, et al. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term followup study. J Child Neurol 2005; 20: 893-897.
    • (2005) J Child Neurol , vol.20 , pp. 893-897
    • Grosso, S.1    Franzoni, E.2    Iannetti, P.3
  • 2
    • 0035282352 scopus 로고    scopus 로고
    • Topiramate in refractory partial-onset seizures in children, adolescents and young adults: A multicentric open trial
    • Coppola G, Caliendo G, Terracciano MM, et al. Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial. Epilepsy Res 2001; 43: 255-260.
    • (2001) Epilepsy Res , vol.43 , pp. 255-260
    • Coppola, G.1    Caliendo, G.2    Terracciano, M.M.3
  • 3
    • 0344688416 scopus 로고    scopus 로고
    • Topiramate in the treatment of myoclonicastatic epilepsy in children: A retrospective hospital audit
    • Jayawant S, Libretto SE. Topiramate in the treatment of myoclonicastatic epilepsy in children: a retrospective hospital audit. J Postgrad Med 2003; 49: 202-205.
    • (2003) J Postgrad Med , vol.49 , pp. 202-205
    • Jayawant, S.1    Libretto, S.E.2
  • 4
    • 0003150278 scopus 로고    scopus 로고
    • An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action
    • Shank R P, Gardocki J F, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000; 41(Suppl): S3-S9.
    • (2000) Epilepsia , vol.41 , Issue.SUPPL.
    • Shank, R.P.1    Gardocki, J.F.2    Streeter, A.J.3    Maryanoff, B.E.4
  • 5
    • 0036344989 scopus 로고    scopus 로고
    • Anhidrosis and hyperthermia associated with treatment with topiramate
    • Nieto-Barrera M, Nieto-Jimenez M, Candau R, et al. Anhidrosis and hyperthermia associated with treatment with topiramate. Rev Neurol 2002; 34: 114-116.
    • (2002) Rev Neurol , vol.34 , pp. 114-116
    • Nieto-Barrera, M.1    Nieto-Jimenez, M.2    Candau, R.3
  • 6
    • 33745625703 scopus 로고    scopus 로고
    • Hypohidrosis during topiramate treatment: A rare and reversible side effect
    • Cerminara C, Seri S, Bombardieri R, et al. Hypohidrosis during topiramate treatment: a rare and reversible side effect. Pediatr Neurol 2006; 34: 392-394.
    • (2006) Pediatr Neurol , vol.34 , pp. 392-394
    • Cerminara, C.1    Seri, S.2    Bombardieri, R.3
  • 7
    • 41449093731 scopus 로고    scopus 로고
    • Topiramate associated hypohidrosis and hyperthermia
    • Incecik F, Hergüner MO, Altunbasak S. Topiramate associated hypohidrosis and hyperthermia. Indian Pediatr 2008; 45: 238-240.
    • (2008) Indian Pediatr , vol.45 , pp. 238-240
    • Incecik, F.1    Hergüner, M.O.2    Altunbasak, S.3
  • 8
    • 76249125935 scopus 로고    scopus 로고
    • Hypohidrosis related symptoms in pediatric epileptic patients with topiramate
    • Kim SC, Seol IJ, Kim SJ. Hypohidrosis related symptoms in pediatric epileptic patients with topiramate. Pediatr Int 2010; 52: 109-112.
    • (2010) Pediatr Int , vol.52 , pp. 109-112
    • Kim, S.C.1    Seol, I.J.2    Kim, S.J.3
  • 9
    • 0034115766 scopus 로고    scopus 로고
    • Topiramate as an inhibitor of carbonic anhydrase isoenzymes
    • Dodgson SJ, Shank R P, Maryanoff BF. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000; 41: 35-39.
    • (2000) Epilepsia , vol.41 , pp. 35-39
    • Dodgson, S.J.1    Shank, R.P.2    Maryanoff, B.F.3
  • 10
    • 26444527980 scopus 로고    scopus 로고
    • Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia
    • Ziad el K, Rahi AC, Hamdan SA, et al. Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia. Neurology 2005; 65: 1139-1140.
    • (2005) Neurology , vol.65 , pp. 1139-1140
    • Ziad el, K.1    Rahi, A.C.2    Hamdan, S.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.